Skip to main content

Table 2 Relation of baseline parameters of patients with complete remission (CR) in lupus nephritis

From: Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study

Parameters

CR (n = 18)

No CR (n = 23)

P value

Mean age in years

27.2 (±9.1)

27 (±11.3)

0.97

Mean duration of symptoms in days

438 (±541)

452(±1113)

0.96

Mean SBP in mmHG

124 (±20)

131(±22)

0.28

Mean DBP in mmHG

79 (±12.8)

83 (±12.1)

0.35

Mean eGFR in ml/min

54.5 (±33.9)

61.4 (±36.7)

0.54

Mean serum albumin in g/L

24.8 (±6.3)

18.6 (±4.8)

0.01

Number of patients with serum albumin

 ≥ 20 g/L

14 (77.8 %)

8 (34.8 %)

0.006

 < 20 g/L

4 (22.2 %)

15 (65.2 %)

 

Number of patients with UTP (mg/day)

 ≥ 3000

6 (33.3 %)

16 (69.6 %)

0.02

 < 3000

12 (66.7 %)

7 (30.4 %)

 

Number of patient with AI

 >7

8 (50 %)

13 (61.9 %)

0.67

 ≤7

8 (50 %)

8 (38.1 %)

 

Number of patient with CI

 > 3

4 (25 %)

8(38.1 %)

0.34

 ≤ 3

12 (75 %)

13 (61.9 %)

 

Number of patients with combined

 AI >7 & CI >3

2 (12.5 %)

4 (19 %)

0.54

 AI ≤7 & CI ≤ 3

14 (87.5 %)

17 (81 %)

 

Number of patients in different classes of LN

 III

4 (80 %)

1 (20 %)

0.29

 IV

9 (40.1 %)

13 (59.1 %)

 

 V

1 (25 %)

3 (75 %)

 

 III + V

1 (20 %)

4 (80 %)

 

 IV + V

3 (60 %)

2 (40 %)

 

Number of patients

 Dialyzed

0

4 (100 %)

0.06

 Not dialyzed

18 (48.6 %)

19 (51.4 %)

 
  1. SBP systolic blood pressure, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, UTP urinary total protein, AI activity index, CI chronicity index, (±) standard deviation